chr6-31026072-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001395414.1(MUC22):āc.641A>Gā(p.Glu214Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000457 in 1,530,786 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001395414.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
MUC22 | NM_001395414.1 | c.641A>G | p.Glu214Gly | missense_variant | 2/4 | ENST00000561890.1 | |
MUC22 | NM_001318484.1 | c.650A>G | p.Glu217Gly | missense_variant | 3/5 | ||
MUC22 | NM_001198815.1 | c.641A>G | p.Glu214Gly | missense_variant | 3/5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
MUC22 | ENST00000561890.1 | c.641A>G | p.Glu214Gly | missense_variant | 2/4 | 2 | NM_001395414.1 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00000658 AC: 1AN: 151886Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000155 AC: 2AN: 128624Hom.: 0 AF XY: 0.0000142 AC XY: 1AN XY: 70290
GnomAD4 exome AF: 0.00000435 AC: 6AN: 1378782Hom.: 0 Cov.: 86 AF XY: 0.00000441 AC XY: 3AN XY: 680326
GnomAD4 genome AF: 0.00000658 AC: 1AN: 152004Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74314
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 31, 2023 | The c.641A>G (p.E214G) alteration is located in exon 3 (coding exon 2) of the MUC22 gene. This alteration results from a A to G substitution at nucleotide position 641, causing the glutamic acid (E) at amino acid position 214 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at